Munich - Delayed Quote • EUR Pactiv Evergreen Inc. (PEG.MU) Follow Compare 17.00 0.00 (0.00%) At close: January 30 at 8:04:12 AM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Pactiv Evergreen Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period for Planned Acquisition by Novolex LAKE FOREST, Ill., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Pactiv Evergreen Inc. (“Pactiv Evergreen” or the “Company”) (NASDAQ: PTVE) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the Company’s previously announced definitive agreement to be acquired by Novolex® for $18.00 per share in cash. The transaction is expected to close in the second quarter of 2025, subject to receipt of foreign antitrust approvals and sa Pactiv Evergreen’s moulded fibre egg packaging receives FSC certification The certification is aligned with the company's Packaging a Better Future vision. Pactiv Evergreen Earns FSC®-Recycled Certification for Molded Fiber Egg Packaging Featured at IPPE Expo in Atlanta, Georgia from January 28-30, 2025LAKE FOREST, Ill., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Pactiv Evergreen’s molded fiber egg cartons and filler flats have been certified by the Forest Stewardship Council® (FSC®) as being made from 100 percent recycled materials. This significant milestone reinforces the Company’s purpose of Packaging a Better Future by protecting the planet’s natural resources. This certification, under Pactiv Evergreen’s FSC C125335 license, applie Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio? These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? Patterson Companies, Inc. (NASDAQ:PDCO) stock rocketed 35.60% after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital for approximately $4.1 billion. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) g Should You Buy Pactiv Evergreen Inc. (PTVE) After Golden Cross? When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react? Pactiv Evergreen price target raised to $18 from $12 at Baird Baird analyst Ghansham Panjabi raised the firm’s price target on Pactiv Evergreen (PTVE) to $18 from $12 and keeps a Neutral rating on the shares. The firm noted the $18 takeout price and reiterated their view that after a lull in activity, the Packaging industry is in the initial stages of a long-tailed consolidation cycle, which while thus far is in the plastics packaging substrate, is likely to be broad-based. Published first on TheFly – the ultimate source for real-time, market-moving breaki Novolex to merge with Pactiv Evergreen in $6.7bn deal The merger has the financial backing of Apollo Funds and CPP Investments, contributing approximately $1bn. Apollo-Backed Novolex to Buy Pactiv Evergreen for $3.22 Billion Novolex, a packaging company backed by Apollo Global Management, struck a deal to buy publicly traded Pactiv Evergreen for around $3.22 billion Update: Pactiv Evergreen Shares Rise After $6.7 Billion Acquisition Deal With Apollo's Novolex (Updates with stock move in the headline and first paragraph, and additional details in the third an Top Midday Stories: China Probing Nvidia Over Potential Anti-Monopoly Law Breaches; Gallagher to Acquire AssuredPartners for $13.45 Billion All three major US stock indexes were down in late morning trading Monday, as investors look ahead t Pactiv Evergreen to Be Taken Private by Apollo-Backed Novolex in $6.7 Billion All-Cash Deal Pactiv Evergreen (PTVE) agreed to be acquired and taken private by Novolex in an all-cash deal worth Apollo-owned Novolex to take packaging products maker Pactiv private in $6.7 billion deal Novolex will offer $18 per share to take Pactiv private in an all-cash transaction, including debt, the companies said on Monday. The deal represents a 32.4% premium to Pactiv's closing price on Dec. 2, a day before Bloomberg News first reported that Novolex was considering purchasing the company. Shares of Pactiv, which sells its products to restaurants, retailers, food and beverage producers, packers and processors, jumped about 19%. Novolex and Pactiv Evergreen Inc. to Combine, Establishing a Leading Manufacturer in Food and Beverage Packaging Pactiv Evergreen Shareholders to Receive $18.00 Per Share in Cash Complementary products, focus on innovation and sustainability create partner of choice across the food and beverage packaging industry Customer-centric, packaging solutions provider across substrates with a North American footprint and broad distribution capabilities CHARLOTTE, N.C. and LAKE FOREST, Ill., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Novolex® and Pactiv Evergreen Inc. (NASDAQ: PTVE), announced today they have entered into a Novolex to acquire Pactiv Evergreen in $6.7B deal The North American companies expect to finalize the all-cash deal in 2025, which would take Pactiv Evergreen private. Just Three Days Till Pactiv Evergreen Inc. (NASDAQ:PTVE) Will Be Trading Ex-Dividend Pactiv Evergreen Inc. ( NASDAQ:PTVE ) is about to trade ex-dividend in the next three days. The ex-dividend date is... Results: Pactiv Evergreen Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts Investors in Pactiv Evergreen Inc. ( NASDAQ:PTVE ) had a good week, as its shares rose 4.5% to close at US$12.29... Pactiv Evergreen (NASDAQ:PTVE) Has Announced A Dividend Of $0.10 Pactiv Evergreen Inc. ( NASDAQ:PTVE ) will pay a dividend of $0.10 on the 13th of December. This makes the dividend... PTVE or ATR: Which Is the Better Value Stock Right Now? PTVE vs. ATR: Which Stock Is the Better Value Option? Q3 2024 Pactiv Evergreen Inc Earnings Call Q3 2024 Pactiv Evergreen Inc Earnings Call Pactiv Evergreen Inc (PTVE) Q3 2024 Earnings Call Highlights: Strategic Shifts and Financial ... Pactiv Evergreen Inc (PTVE) reports solid EBITDA margins and strategic divestitures, despite facing revenue declines and inflationary pressures. Performance Overview Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return PEG.MU S&P 500 YTD +1.80% +2.78% 1-Year +29.41% +23.20% 3-Year +94.57% +36.99%